Epigenetically mediated downregulation of the differentiation-promoting chaperon protein CRABP2 in astrocytic gliomas

International Journal of Cancer

Volumn 131, Issue 8, 2012, Pages 1963-1968

  Campos, Benito ^a   Warta, Rolf ^a   Chaisaingmongkol, Jittiporn ^b   Geiselhart, Lea ^b   Popanda, Odilia ^b   Hartmann, Christian ^a   Von Deimling, Andreas ^a   Unterberg, Andreas ^a   Plass, Christoph ^b   Schmezer, Peter ^b   Herold Mende, Christel ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CRABP2; differentiation; glioma; methylation; retinoic acid

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CELLULAR RETINOIC ACID BINDING PROTEIN 2; CHAPERONE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CRABP2 GENE; DNA METHYLATION; DOWN REGULATION; ENZYME REGULATION; EPIGENETICS; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE SEQUENCE; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL;

ASTROCYTOMA; BRAIN; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOCITRATE DEHYDROGENASE; NEOPLASM GRADING; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION;

EID: 84865310856     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27446     Document Type: Article

References (22)

1. Giguø̈re V,. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 1994; 15: 61-79.
2. Blomhoff R, Blomhoff HK,. Overview of retinoid metabolism and function. J Neurobiol 2006; 66: 606-30. (Pubitemid 43941649)
3. Chambon P,. A decade of molecular biology of retinoic acid receptors. FASEB J 1996; 10: 940-54. (Pubitemid 26285969)
4. Chakravarti N, Lotan R, Diwan AH, Warneke CL, Johnson MM, Prieto VG,. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res 2007; 13: 4817-24. (Pubitemid 47294789)
5. Tanabe K, Utsunomiya H, Tamura M, Niikura H, Takano T, Yoshinaga K, Nagase S, Suzuki T, Ito K, Matsumoto M, Hayashi S, Yaegashi N,. Expression of retinoic acid receptors in human endometrial carcinoma. Cancer Sci 2008; 99: 267-71. (Pubitemid 351228479)
6. Widschwendter M, Berger J, Daxenbichler G, Müller-Holzner E, Widschwendter A, Mayr A, Marth C, Zeimet AG,. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancer. Cancer Res 1997; 57: 4158-61. (Pubitemid 27413413)
7. Campos B, Centner F-S, Bermejo JL, Ali R, Dorsch K, Wan F, Felsberg J, Ahmadi R, Grabe N, Reifenberger G, Unterberg A, Burhenne J, et al. Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas. Am J Pathol 2011; 178: 1953-64.
8. Delva L, Bastie JN, Rochette-Egly C, Kraø®ba R, Balitrand N, Despouy G, Chambon P, Chomienne C,. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999; 19: 7158-67. (Pubitemid 29441896)
9. Sessler RJ, Noy N,. A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II. Mol Cell 2005; 18: 343-53. (Pubitemid 41350539)
10. Beier D, Wischhusen J, Dietmaier W, Hau P, Proescholdt M, Brawanski A, Bogdahn U, Beier CP,. CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 2008; 18: 370-77. (Pubitemid 351782845)
11. Lamszus K, Günther HS,. Glioma stem cells as a target for treatment. Target Oncol 2010; 5: 211-5.
12. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC,. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14: 123-9. (Pubitemid 351377986)
13. Thon N, Damianoff K, Hegermann J, Grau S, Krebs B, Schnell O, Tonn J-C, Goldbrunner R,. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas. Mol Cell Neurosci 2010; 43: 51-9.
14. Calmon MF, Rodrigues RV, Kaneto CM, Moura RP, Silva SD, Mota LDC, Pinheiro DG, Torres C, de Carvalho AF, Cury PM, Nunes FD, Nishimoto IN, et al. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia 2009; 11: 1329-39.
15. Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G, Cantor CR, Field JK, van den Boom D,. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005; 102: 15785-90. (Pubitemid 41552820)
16. Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi A, Gdynia G, Penzel R, et al. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 2010; 52: 2023-33.
17. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T,. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005; 21: 4067-8. (Pubitemid 41631851)
18. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, Combs SE, Goidts V, et al. Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16: 2715-28.
19. Karcher S, Steiner H-H, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C,. Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 2006; 118: 2182-9.
20. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RGW, Hoadley KA, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010; 17: 510-22.
21. Barbus S, Tews B, Karra D, Hahn M, Radlwimmer B, Delhomme N, Hartmann C, Felsberg J, Krex D, Schackert G, Martinez R, Reifenberger G, et al. Differential retinoic acid signaling in tumors of long- and short-term glioblastoma survivors. J Natl Cancer Inst 2011; 103: 598-606.
22. Corlazzoli F, Rossetti S, Bistulfi G, Ren M, Sacchi N,. Derangement of a factor upstream of RARalpha triggers the repression of a pleiotropic epigenetic network. PLoS One 2009; 4: e4305.